IBDEI2R9 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43944,2)
 ;;=^5003509
 ;;^UTILITY(U,$J,358.3,43945,0)
 ;;=A81.00^^164^2169^8
 ;;^UTILITY(U,$J,358.3,43945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43945,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,43945,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,43945,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,43946,0)
 ;;=A81.09^^164^2169^7
 ;;^UTILITY(U,$J,358.3,43946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43946,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Other
 ;;^UTILITY(U,$J,358.3,43946,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,43946,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,43947,0)
 ;;=A81.2^^164^2169^29
 ;;^UTILITY(U,$J,358.3,43947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43947,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,43947,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,43947,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,43948,0)
 ;;=F01.51^^164^2169^32
 ;;^UTILITY(U,$J,358.3,43948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43948,1,3,0)
 ;;=3^Vascular Dementia w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,43948,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,43948,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,43949,0)
 ;;=G30.9^^164^2169^4
 ;;^UTILITY(U,$J,358.3,43949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43949,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,43949,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,43949,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,43950,0)
 ;;=G31.01^^164^2169^27
 ;;^UTILITY(U,$J,358.3,43950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43950,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,43950,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,43950,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,43951,0)
 ;;=G94.^^164^2169^6
 ;;^UTILITY(U,$J,358.3,43951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43951,1,3,0)
 ;;=3^Brain D/O in Diseases Classified Elsewhere NEC
 ;;^UTILITY(U,$J,358.3,43951,1,4,0)
 ;;=4^G94.
 ;;^UTILITY(U,$J,358.3,43951,2)
 ;;=^5004187
 ;;^UTILITY(U,$J,358.3,43952,0)
 ;;=G31.83^^164^2169^17
 ;;^UTILITY(U,$J,358.3,43952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43952,1,3,0)
 ;;=3^Dementia w/ Lewy Bodies
 ;;^UTILITY(U,$J,358.3,43952,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,43952,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,43953,0)
 ;;=G31.89^^164^2169^11
 ;;^UTILITY(U,$J,358.3,43953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43953,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System NEC
 ;;^UTILITY(U,$J,358.3,43953,1,4,0)
 ;;=4^G31.89
 ;;^UTILITY(U,$J,358.3,43953,2)
 ;;=^5003814
 ;;^UTILITY(U,$J,358.3,43954,0)
 ;;=G31.9^^164^2169^12
 ;;^UTILITY(U,$J,358.3,43954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43954,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System,Unspec
 ;;^UTILITY(U,$J,358.3,43954,1,4,0)
 ;;=4^G31.9
 ;;^UTILITY(U,$J,358.3,43954,2)
 ;;=^5003815
 ;;^UTILITY(U,$J,358.3,43955,0)
 ;;=G23.8^^164^2169^10
 ;;^UTILITY(U,$J,358.3,43955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43955,1,3,0)
 ;;=3^Degenerative Diseases of Basal Ganglia NEC
 ;;^UTILITY(U,$J,358.3,43955,1,4,0)
 ;;=4^G23.8
 ;;^UTILITY(U,$J,358.3,43955,2)
 ;;=^5003782
 ;;^UTILITY(U,$J,358.3,43956,0)
 ;;=G30.0^^164^2169^2
 ;;^UTILITY(U,$J,358.3,43956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43956,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,43956,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,43956,2)
 ;;=^5003805
